BridgeBio Pharma, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
BBIO on Nasdaq
Location
Palo Alto, CA
Fiscal year end
31 December
Latest financial report
24 Feb 2026

Shareable Research Card

BBIO - BridgeBio Pharma, Inc. Financial Facts

BBIO - BridgeBio Pharma, Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q4 2025
Latest reported value
Operating Margin -104%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub Which companies report the highest revenue?

Quick Takeaways

  • BBIO - BridgeBio Pharma, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Operating Margin -104%.

What Changed

  • Operating Margin YoY change: <span class="text-red-600">-61%</span>.
  • Most recent SEC facts end date: 12 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2026-02-12) highlights Operating Margin -104.2%, Current Ratio 2.77x, and Quick Ratio 2.46x.

Compare This Company Through SEC-backed Metrics

Use these links to compare BBIO - BridgeBio Pharma, Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

52.3/100

Caution Confidence low

Financial Health

Current Ratio
2.77x
Quick Ratio
2.46x
Debt to Equity
-1.52x

Strengths

Current Ratio and Revenues YoY

Watchpoints

Operating Margin and Debt-to-equity

Key metrics snapshot

Operating Margin

-104%

YoY: -61%

Industry median: -121% (n=298)

View history

Current Ratio

2.77x

YoY: -41%

Industry median: 3.39x (n=667)

View history

Quick Ratio

2.46x

YoY: -45%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

-1.52x

YoY: -8.5%

Industry median: 0.26x (n=530)

View history

Revenues YoY

126%

YoY:

Industry median: 7.3% (n=302)

View history

Profitability

Metric Latest value YoY change
Operating Margin -104% -61%

Financial Health

Metric Latest value YoY change
Current Ratio 2.77x -41%
Quick Ratio 2.46x -45%
Debt-to-equity -1.52x -8.5%

Growth

Metric Latest value YoY change
Revenues YoY 126%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 193,862,871 +1.9%
Common Stock, Shares, Outstanding 194,771,957 +2.5%
Common Stock, Value, Issued $202,000 +3.1%
Weighted Average Number of Shares Outstanding, Basic 191,527,482 +2.9%
Weighted Average Number of Shares Outstanding, Diluted 191,527,482 +2.9%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $502,076,000 +126%
Cost of Revenue $20,962,000 +441%
Research and Development Expense $451,953,000 -11%
Costs and Expenses $1,025,487,000 +26%
Operating Income (Loss) $523,411,000 +12%
Nonoperating Income (Expense) $209,092,000 -512%
Income Tax Expense (Benefit) $435,000 -62%
Earnings Per Share, Basic -3.78 -31%
Earnings Per Share, Diluted -3.78 -31%
Cash and Cash Equivalents, at Carrying Value $570,119,000 -16%
Accounts Receivable, after Allowance for Credit Loss, Current $139,444,000 +2853%
Inventory, Net $26,753,000
Assets, Current $797,749,000 +11%
Property, Plant and Equipment, Net $5,366,000 -23%
Operating Lease, Right-of-Use Asset $8,149,000 +41%
Intangible Assets, Net (Excluding Goodwill) $28,077,000 +17%
Other Assets, Noncurrent $16,712,000 -8.2%
Assets $936,025,000 +1.8%
Accounts Payable, Current $36,228,000 +277%
Employee-related Liabilities, Current $76,703,000 +32%
Contract with Customer, Liability, Current $7,190,000 -51%
Liabilities, Current $287,971,000 +87%
Contract with Customer, Liability, Noncurrent $13,080,000 -23%
Operating Lease, Liability, Noncurrent $3,811,000 -19%
Other Liabilities, Noncurrent $244,000 -15%
Liabilities $3,012,606,000 +27%
Accumulated Other Comprehensive Income (Loss), Net of Tax $12,000 +50%
Retained Earnings (Accumulated Deficit) $3,821,194,000 -23%
Stockholders' Equity Attributable to Parent $2,086,610,000 -42%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2,076,011,000 -42%
Liabilities and Equity $936,025,000 +1.8%
Common Stock, Shares Authorized 500,000,000 0%
Common Stock, Shares, Issued 202,369,129 +3.1%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $572,140,000 -16%
Deferred Tax Assets, Valuation Allowance $968,021,000 +33%
Deferred Tax Assets, Gross $969,572,000 +33%
Operating Lease, Liability $10,003,000 +8.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $724,927,000 -35%
Lessee, Operating Lease, Liability, to be Paid $10,873,000 +7.6%
Operating Lease, Liability, Current $6,192,000 +37%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,320,000 -47%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,642,000 +35%
Operating Lease, Weighted Average Discount Rate, Percent 0.068 +13%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $870,000 -3.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three $976,000 +124%
Deferred Tax Assets, Operating Loss Carryforwards $490,732,000 +29%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 25,000,000 0%
Unrecognized Tax Benefits $43,979,000 +19%
Lessee, Operating Lease, Liability, to be Paid, Year Four $494,000 +13%
Additional Paid in Capital $2,057,646,000 +8.1%
Preferred Stock, Shares Outstanding 0
Amortization of Intangible Assets $2,700,000 +12%
Deferred Tax Assets, Net of Valuation Allowance $1,551,000 +18%
Share-based Payment Arrangement, Expense $136,882,000 +20%
Preferred Stock, Par or Stated Value Per Share 0.001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY